ShareValue scores for ALBIO.PA: Valuation 74, Quality 56, Growth 47, Health 32.

ALBIO.PA
Euronext Paris

Biosynex

€0.91(+0.44%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

11% to 28%
Valuation
74
Undervalued
Price vs Value
Quality
56
Moderate
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
32
Stressed
Financial Stability
Momentum
83
Bullish
Price Trend

Company Details

About

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026